Drug interactions
Carbidopa-levodopa + Oxybutynin transdermal
Severity: Minor
Carbidopa-levodopa and Oxybutynin transdermal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxybutynin is an anticholinergic, and anticholinergics are often used in parkinsonism, so a direct loss of levodopa effect is not expected. The main concerns are additive anticholinergic adverse effects such as confusion, hallucinations, constipation and urinary retention, and a possible slowing of gastric emptying that may delay levodopa absorption. With the transdermal route, systemic exposure is lower than with oral dosing.
What this interaction means in plain words
Carbidopa-levodopa and Oxybutynin transdermal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive central and peripheral anticholinergic effects, with possible reduced gastric motility delaying levodopa absorption.
What to do
Monitor for cognitive effects, hallucinations and constipation, especially in older patients. Review levodopa response if motor fluctuations develop.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carbidopa-levodopa and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Carbidopa-levodopa
- Carbidopa-levodopa + Isocarboxazid Contraindicated
- Carbidopa-levodopa + Phenelzine Contraindicated
- Carbidopa-levodopa + Selegiline transdermal Contraindicated
- Carbidopa-levodopa + Tranylcypromine Contraindicated
- Amisulpride + Carbidopa-levodopa Major
- Asenapine + Carbidopa-levodopa Major
Frequently asked questions
Can I take Carbidopa-levodopa with Oxybutynin transdermal?
MediHelp rates the interaction as minor. Carbidopa-levodopa and Oxybutynin transdermal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Oxybutynin is an anticholinergic, and anticholinergics are often used in parkinsonism, so a direct loss of levodopa effect is not expected. The main concerns are additive anticholinergic adverse effects such as confusion, hallucinations, constipation and urinary retention, and a possible slowing of gastric emptying that may delay levodopa absorption. With the transdermal route, systemic exposure is lower than with oral dosing.
How serious is the interaction between Carbidopa-levodopa and Oxybutynin transdermal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for cognitive effects, hallucinations and constipation, especially in older patients. Review levodopa response if motor fluctuations develop.
What other medicines interact with Carbidopa-levodopa?
MediHelp also lists interactions of Carbidopa-levodopa with, for example, Isocarboxazid, Phenelzine, Selegiline transdermal. The full list is on the Carbidopa-levodopa page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
